VEGF-A (VEGF120) Mouse Protein

CAT#: AR26013PU-N

VEGF-A (VEGF120) mouse recombinant protein, 5 µg



Need it in bulk or customized?
Get a free quote

CNY 4,690.00


货期*
7周

规格
    • 5 ug

Product images

Specifications

Product Data
Species Mouse
Expression Host E. coli
Expression cDNA Clone or AA Sequence
APTTEGEQKS HEVIKFMDVY QRSYCRPIET LVDIFQEYPD EIEYIFKPSC VPLMRCAGCC NDEALECVPT SESNITMQIM RIKPHQSQHI GEMSFLQHSR CECRPKKDRT KPEKCDKPRR
Predicted MW 28.2 kDa
Purity >95% by SDS-PAGE and silver stain
Buffer Presentation State: Purified
State: Lyophilized protein
Buffer System: 50 mM Acetic Acid
Stabilizer: None
Preparation Lyophilized protein
Protein Description Recombinant Murine Vascular Endothelial Growth Factor120
Note Range: 1.0-10.0 ng/ml
Protein RefSeq: NP 001020421
mRNA RefSeq: NM 001025250
Storage The lyophilized protein is stable at 2-8°C for up to 1 week or at -20°C for longer.
Following reconstitution store (in aliquots) at -20°C.
Avoid repeated freezing and thawing.
Stability Shelf life: one year from despatch.
Bioactivity Biological: Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1-10 ng/ml.
Endotoxin < 0.1 ng/µg of VEGF120
Reference Data
RefSeq NP_001020421
Locus ID 22339
UniProt ID Q00731
Cytogenetics 17 22.79 cM
Synonyms VEGFA, VEGF, VPF, Vascular endothelial growth factor A, Vascular permeability factor
Summary This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site.[provided by RefSeq, Nov 2015]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Customer Reviews 
Loading...